AI3 Bio, Inc.

New Filing

CIK: 0002019875·Biotechnology·DELAWARE·Filed: Nov 4, 2026

Total Offering

Indefinite

Amount Sold

$0

Investors

7

First Sale

Jun 9, 2026

Offering Details

Type: Equity
Exemptions: Rule 506(b)
Entity Type: Corporation
Non-Accredited Investors: No

Related Persons

Name	Role
Steven Altschuler	Related Person
Michael Lyman	Related Person
Nick Seaver	Related Person
Fabian Tenenbaum	Related Person
Jeanne Cunicelli	Related Person
Alan Ezekowitz	Related Person
Jonathan Kagan	Related Person

Company

99 COOLIDGE AVE, SUITE 201

WATERTOWN, MA, 02472

617-701-7014

SEC Filing

0002019875-26-000004

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.